|
If
you are interested in participating in the following trial, please contact
the relevant Trial Chairperson or Trial Centre Data Manager.
Date first patient entered: 6 January 2006
Target Accrual: 280
Aim: The principal aim of the study is to assess the independent prognostic significance, with respect to overall survival, of the factors, FIGO stage, tumour volume and corpus invasion, in radically treated cervical cancer patients.
Trial Contacts: TROG Trial Chairperson
Assoc Prof Kailash Narayan Narayan
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne
Fax: +61 3 9656 1424
Trial Centre Data Manager
Rachael Koelmeyer
Peter MacCallum Cancer Centre
St Andrews Place, East Melbourne
Fax: + +61 3 9656 1420
More Information
[ Open
Trials - Home ]

|